Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment

Background: Given that residual congestion is a predictor of poor outcome in patients with heart failure (HF), a therapeutic strategy for decongestion is required. Methods and Results: Eighteen HF patients with fluid retention despite oral furosemide >20 mg/day, with chronic kidney disease (CKD;...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Toshiki, Minatoguchi, Shingo, Yamada, Yoshihisa, Kanamori, Hiromitsu, Kawasaki, Masanori, Nishigaki, Kazuhiko, Minatoguchi, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925130/
https://www.ncbi.nlm.nih.gov/pubmed/33693073
http://dx.doi.org/10.1253/circrep.CR-18-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925130/
https://www.ncbi.nlm.nih.gov/pubmed/33693073
http://dx.doi.org/10.1253/circrep.CR-18-0002

Ejemplares similares